Back to User profile » Prof. Dr. Silvio Danese
Papers published by Prof. Dr. Silvio Danese:
Optimising Monoclonal Antibody Drug Development for Inflammatory Bowel Disease
Colwill M, Honap S, Danese S, Peyrin-Biroulet L
Clinical and Experimental Gastroenterology 2025, 18:233-249
Published Date: 30 September 2025
Positioning Guselkumab in The Treatment Algorithm of Patients with Crohn’s Disease
D’Amico F, Bencardino S, Magro F, Dignass A, Gutiérrez Casbas A, Verstockt B, Hart A, Armuzzi A, Peyrin-Biroulet L, Danese S
Biologics: Targets and Therapy 2025, 19:351-363
Published Date: 31 May 2025
Magnetic Resonance Enterography Assessment of Transmural Healing with Vedolizumab in Moderate to Severe Crohn’s Disease: Feasibility in the VERSIFY Phase 3 Clinical Trial
Rimola J, Colombel JF, Bressler B, Adsul S, Siegelman J, Cole PE, Lindner D, Danese S
Clinical and Experimental Gastroenterology 2024, 17:9-23
Published Date: 27 January 2024
Resolved Hypereosinophilic Syndrome and Immune Thrombocytopenic Purpura in Ulcerative Colitis Patients Post Colectomy: A Case Series and Literature Review
Subki AH, Bokhary MI, Alandijani SA, Aljehani MA, Alharbi AW, Alzahrani M, Almuhammadi SS, Albeirouti BT, Abduljabar MA, Danese S
Journal of Inflammation Research 2022, 15:6373-6380
Published Date: 21 November 2022
Evaluating Upadacitinib in the Treatment of Moderate-to-Severe Active Ulcerative Colitis: Design, Development, and Potential Position in Therapy
Napolitano M, D'Amico F, Ragaini E, Peyrin-Biroulet L, Danese S
Drug Design, Development and Therapy 2022, 16:1897-1913
Published Date: 17 June 2022
